<DOC>
	<DOCNO>NCT02146911</DOCNO>
	<brief_summary>Clinically proven medication nicotine replacement therapy , bupropion varenicline available help smoker quit widely use . The primary objective study evaluate real-world long-term effectiveness bupropion varenicline treatment community sample smoker interested quitting . The investigator hypothesize varenicline treatment result high quit rate end treatment one year treatment compare bupropion . Smoking status biochemically confirm various time point use salivary cotinine measure . Furthermore , since 50 % variation quit success genetically determine , effectiveness different cessation medication may differ considerably sub-groups smoker carry certain genetic variant , investigator collect saliva sample consent participant evaluate moderate effect genetics treatment response .</brief_summary>
	<brief_title>The MATCH ( Medication Aids Tobacco Cessation Health ) Study</brief_title>
	<detailed_description>Only fraction smoker receive information effective prescription-only smoking pharmacotherapies , bupropion varenicline . Moreover , study demonstrate variable smoking cessation treatment outcomes correlate individual ' genotype phenotype . Mass distribution approach , bypass clinic physician , successful nicotine replacement therapy . The primary objective study evaluate real-world long-term effectiveness mail bupropion varenicline treatment sample interested smoker , utilize web-based recruitment follow-up . As part Genetics Sub-study , pharmacogenetics smoke cessation medication investigate . This open label study , wherein eligible participant randomize receive bupropion ( Zyban® ) varenicline ( Champix® ) 12 week conjunction weekly motivational email . Participants spend approximately 20-30 minute enrol study study 's website . During time , read consent form , answer eligibility question complete baseline questionnaire . Eligible participant ask interested participate Genetics Sub-study . Those provide separate consent genetics component complete additional questionnaire online ( Between Facets Domains Personality Test ) mail kit provide saliva sample . After successful completion baseline questionnaire study website , eligible participant email Letter Doctor Standard Script take doctor . Then , attend appointment physician discus doctor whether medication assign appropriate use smoke cessation aid . It possible participant his/her doctor decide pursue smoking cessation use assigned medication . These participant still receive weekly motivational email follow time point , include main data analysis . If doctor believe appropriate participant take assign medication , he/she need sign Standard Script fax study contract pharmacy . Once fax receive pharmacy , call participant brief counseling . Then , fill prescription mail medication free charge . All participant set quit date choosing , start medication 7 day prior target quit date . Data relate outcome measure adverse event collect 4 , 8 12 , 26 52 week start treatment order ass compare point prevalent continuous abstinence effect two treatment intervention . Smoking status biochemically confirm baseline 26th 52nd week follow start treatment use salivary cotinine measure . Medication compliance assess self-report measure part follow-up questionnaire . Compliance also biochemically confirm 4 week follow start treatment .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>At least 19 year age Smoking least 10 cigarette per day Smoked daily least past year Have intention quit smoke next 30 day . History psychotic disorder eat disorder Brain injury Seizure disorder Pregnancy , lactation , risk become pregnant Allergy sensitivity bupropion varenicline Taking monoamine oxidase inhibitor ( antidepressant ) , thioridazine Wellbutrin medication contain bupropion hydrochloride .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Smoking Cessation Medication</keyword>
	<keyword>Smoking Treatment</keyword>
	<keyword>Tobacco Treatment</keyword>
	<keyword>Quitting Smoking</keyword>
	<keyword>Bupropion</keyword>
	<keyword>Varenicline</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Pharmacogenetics Smoking Treatment</keyword>
	<keyword>Genetics analysis</keyword>
	<keyword>Smoking Personality</keyword>
	<keyword>Dependence</keyword>
	<keyword>Addiction</keyword>
	<keyword>Cigarettes</keyword>
	<keyword>Primary Care Physicians</keyword>
	<keyword>Biochemical Confirmation</keyword>
</DOC>